B+
Bull case
25%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-04-18 · RankAlpha Sentiment Codex
PROF
Profound MedicalCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The bullish case is that 2025 showed real top-line traction: revenue rose 51% to $16.1M, recurring non-capital revenue rose to $9.73M, and management is explicitly investing behind direct sales and utilization growth for TULSA-PRO [#10-K-2026-03-05]. If quarterly updates confirm continued system placements and procedure growth, the current micro-cap valuation can rerate quickly.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Commercial adoption of TULSA-PRO may remain slower than the cost ramp behind the direct sales build-out.
Momentum
70
Value
37
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.25 · Bull $9.50 · Bear $4.25Analysis 2026-04-18; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $11.14
Why
Momentum70 · Δ7d -
Value37 · Δ7d -0.0
Sentiment68 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Commercial adoption of TULSA-PRO may remain slower than the cost ramp behind the direct sales build-out.
- • Hospital capital budgeting and procedure adoption cycles can stay lumpy, making quarterly results volatile.
- • The bearish case is that PROF remains a low-coverage, loss-making medtech with limited externally confirmed forward demand signals.
Catalyst clock
2026-05-07
Q1 2026 results and business update on May 7, 2026
Lead driver: Sentiment · See AI snapshot
Momentum
70
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
68
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 70.5 / Value 36.6 / Sentiment 68.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-18. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$7.25
Analysis reference price unavailable
Analysis 2026-04-18 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$4.25
Analysis reference price unavailable
Analysis 2026-04-18 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$242.27M
Beta
0.29
Shares Out
36.53M
P/E (TTM) · Derived
-4.7
P/S (TTM)
19.14
P/FCF (TTM) · Derived
-6.17
Rev YoY
+12.3%
EPS YoY
-49.8%
Gross Margin
+71.8%
Op Margin
-185.3%
Net Debt
-$55.01M
Current Ratio
6.46
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data